Oxford Biomedica PLC (LSE:OXB) shares gained 2.28% on 27 July 2026, putting the cell and gene therapy specialist among today's stronger UK-listed performers.
AstraZeneca PLC is one of the world's leading biopharmaceutical companies, focused on discovering, developing and commercializing innovative medicines across several therapeutic areas. The company serves patients globally through an extensive portfolio of approved therapies and an active pipeline of next-generation medicines. Recent strength in …
GSK PLC (LSE)shares advanced1.09% on 27 July 2026, putting the FTSE 100 pharmaceutical company among today's notable gainers. The move comes immediately ahead of GSK's Q2 2026 results and follows an important regulatory success for its expanding oncology portfolio.
LSE:AOTI – AOTI, Inc.was among the strongest-performing healthcare stocks after climbing14.29%on27 July 2026.
LSE:OBD – Oxford BioDynamics Plcwas among the strongest-performing healthcare stocks after advancing12.00%on27 July 2026.
Healthcare continues to rank among the most important sectors within the UK equity market as investors seek companies capable of delivering stable earnings alongside long-term innovation. Demand for medicines, medical technologies and consumer healthcare products remains resilient regardless of economic cycles, making the sector …
RUA Life Sciences Plc (LSE: RUA) rose 4.35% to 24p on the UK gainers screen, giving the company an indicated market value of about £14.89 million. Interim results showed revenue growth, a sharply narrower loss and positive adjusted EBITDA. The move may reflect recognition …
Hemogenyx Pharmaceuticals plc (LSE: HEMO) rose 7.54% to 727p on the latest UK gainers screen. Trading volume was small in absolute terms, and there was no fresh same-day regulatory update identifying a new clinical result. The move may therefore reflect renewed interest in the …
hVIVO plc (LSE: HVO) climbed 11.94% to 7.50p on the latest UK gainers screen, accompanied by trading activity well above its normal level. The move followed a 23 July trading update that offered investors two sharply contrasting messages: weak first-half revenue and profitability, but …
ECO Animal Health Group plc (LSE: EAH) gained 10.38% to 101p on the latest UK market-movers screen. The move came after a strong set of annual results and the commercial launch of ECOVAXXIN MS, the company's first internally developed poultry vaccine. Those developments give …